Business Standard

Saturday, January 11, 2025 | 07:24 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

FDA head says working with India to improve drug quality, safety

She was talking to the media at the end of her visit to India regarding a ban on the shipment of drugs to US

Margaret Hamburg

Reuters Mumbai

The U.S. Food and Drug Administration is working with Indian regulators to enhance the quality and safety of drugs made there, the FDA's Commissioner Margaret Hamburg said on Tuesday.

Hamburg also urged Indian regulators to work closely with their foreign peers.

Hamburg was speaking to reporters at the end of a visit to India which follows FDA decisions to ban the shipment of drugs to the United States from plants of leading Indian drugmakers including Ranbaxy Laboratories Ltd and Wockhardt Ltd .

During a visit that started on February 10, Hamburg met the Indian drugs regulator and health ministry officials as well as executives of local drugmakers.

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 18 2014 | 3:57 PM IST

Explore News